Quarterly report · Q3
2385.TEDINET S100QPPC
Period2022-07-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.6bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2021-07-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥785m | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥931m | 2021-07-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥785m | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥976m | 2021-07-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥784m | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥975m | 2021-07-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥496m | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥810m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥641m | 2021-07-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥500m | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥648m | 2021-07-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥8.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥8.1bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥18.97 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.97 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.95 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.49 | 2021-07-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.62 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥1m |
| Reconciling Itemsreconciling | revenue external | 2022-07-01 → 2023-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥226m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥404m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥404m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥68m |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥3.4bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥3.4bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥701m |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥115m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥382m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥380m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥3m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥43m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥463m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥463m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥83m |
| —segment total | revenue | 2022-07-01 → 2023-03-31 | ¥6.6bn |
| —segment total | revenue external | 2022-07-01 → 2023-03-31 | ¥6.6bn |
| —segment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥3m |
| —segment total | segment profit | 2022-07-01 → 2023-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-03-31 | −¥6m |
| Reconciling Itemsreconciling | revenue external | 2021-07-01 → 2022-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-03-31 | −¥7m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-03-31 | −¥231m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥336m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥336m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2021-07-01 → 2022-03-31 | −¥19m |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥3.7bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥3.7bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥892m |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥2.1bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥2.1bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥124m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥474m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥467m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2021-07-01 → 2022-03-31 | ¥7m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥75m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥453m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥453m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥89m |
| —segment total | revenue | 2021-07-01 → 2022-03-31 | ¥7.1bn |
| —segment total | revenue external | 2021-07-01 → 2022-03-31 | ¥7.1bn |
| —segment total | revenue intersegment | 2021-07-01 → 2022-03-31 | ¥7m |
| —segment total | segment profit | 2021-07-01 → 2022-03-31 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 315
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes | Prior1YTDDuration | 326389000 | JPY |
| Income taxes | CurrentYTDDuration | 283377000 | JPY |
| Profit loss | Prior1YTDDuration | 648234000 | JPY |
| Profit loss | CurrentYTDDuration | 500220000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 7641000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 3999000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 640593000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 496221000 | JPY |
| Profit loss | Prior1YTDDuration | 648234000 | JPY |
| Profit loss | CurrentYTDDuration | 500220000 | JPY |
| Comprehensive income | Prior1YTDDuration | 648234000 | JPY |
| Comprehensive income | CurrentYTDDuration | 500220000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 640593000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 496221000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 7641000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 3999000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | 336232000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05367-000HealthCareSupportServiceReportableSegmentsMember | 452841000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember | 3702513000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalFoodRetailingReportableSegmentsMember | 2133455000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember | 467301000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 7092344000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | 1200000 | JPY |
| Revenues from external customers | Prior1YTDDuration | 7093544000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05367-000HealthCareSupportServiceReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalFoodRetailingReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember | 6834000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 6834000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -6834000 | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | 336232000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05367-000HealthCareSupportServiceReportableSegmentsMember | 452841000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember | 3702513000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalFoodRetailingReportableSegmentsMember | 2133455000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember | 474135000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 7099178000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -5634000 | JPY |
| Net sales | Prior1YTDDuration | 7093544000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | -18513000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05367-000HealthCareSupportServiceReportableSegmentsMember | 88933000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember | 892339000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalFoodRetailingReportableSegmentsMember | 124320000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember | 75356000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1162436000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -231258000 | JPY |
| Operating income | Prior1YTDDuration | 931178000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | 404455000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05367-000HealthCareSupportServiceReportableSegmentsMember | 463329000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |